- Report
- February 2026
- 181 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 179 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 196 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 194 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 192 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 194 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 187 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 196 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 292 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 216 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 178 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 573 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 293 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- February 2026
- 411 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Drug Pipelines
- April 2025
- 400 Pages
Global
From €4389EUR$5,000USD£3,798GBP
- Report
- May 2025
- 120 Pages
Global
From €4170EUR$4,750USD£3,608GBP
- Report
- August 2025
- 154 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- June 2025
- 142 Pages
Global
From €3468EUR$3,950USD£3,000GBP
- Report
- July 2025
- 350 Pages
Global
From €4345EUR$4,949USD£3,759GBP
- Report
- June 2025
- 400 Pages
Global
From €4345EUR$4,949USD£3,759GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more